雲南建投混凝土(01847.HK)預計2025年第一季度新籤銷售合同約8.4億元
格隆匯3月11日丨雲南建投混凝土(01847.HK)公吿,董事會謹此向公司股東及潛在投資者提供以下有關集團業務發展的最新資料:
截至2024年12月31日止年度,集團新籤銷售合同金額合計約為人民幣14.7億元。其中,外部市場再次超過內部市場,與獨立第三方間的新籤銷售合同金額佔比約為51.0%;大項目經營成效明顯,合同金額人民幣1,000萬元以上的大項目佔比約為57.0%。
此外,集團預計將於近期簽署若干銷售合同,經初步預估,2025年第一季度預計新籤銷售合同金額約為人民幣8.4億元,其中,混凝土業務預計新籤銷售合同金額約為人民幣8.1億元;RPC蓋板、預製構件、商品砂漿等新產品預計新籤銷售合同金額約為人民幣0.3億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.